Table 1 Characteristics comparison between participants with and without OSA

Age (years)

47 ± 12

53 ± 15*

Male, n (%)

140 (63.1)

106 (65.4)

BMI (kg/m²)

23.3 ± 5.5

27.8 ± 6.8*

Current smoking, n (%)

78 (35.1)

78 (48.1)^#

Clinic-SBP (mm Hg)

139 ± 15

143 ± 18*

Clinic-DBP (mm Hg)

85 ± 9

86 ± 10

Clinic-HR (bpm)

75 ± 10

79 ± 12

FPG (mmol/L)

5.6 ± 0.4

5.5 ± 0.6

TC (mmol/L)

5.0 ± 0.7

5.2 ± 0.5

TG (mmol/L)

1.8 ± 0.6

1.9 ± 0.8

HDL-C (mmol/L)

1.0 ± 0.4

1.1 ± 0.4

LDL-C (mmol/L)

3.2 ± 0.4

3.4 ± 0.6

Cr (umol/L)

74.9 ± 12.8

71.8 ± 13.6

Hs-CRP (mg/dL)

7.2 ± 3.6

9.7 ± 4.8*

AHI (events/h)

3.4 ± 1.4

11.6 ± 6.2^#

CVD, n (%)

79 (35.6)

66 (40.7)*

Anti-platelet agent, n (%)

98 (44.1)

68 (42.0)

Statins, n (%)

79 (35.6)

59 (36.4)

ACEI/ARB, n (%)

160 (72.1)

119 (73.5)

CCB, n (%)

42 (18.9)

33 (20.4)

Diuretic, n (%)

70 (31.5)

52 (32.1)

Beta-blocker, n (%)

43 (19.4)

37 (22.8)

Alpha-blocker, n (%)

12 (5.4)

10 (6.2)

Anti-HTN medications number

1.7 ± 0.5

2.5 ± 0.8*